L Revert

822 total citations
41 papers, 538 citations indexed

About

L Revert is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, L Revert has authored 41 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in L Revert's work include Vasculitis and related conditions (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers). L Revert is often cited by papers focused on Vasculitis and related conditions (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers). L Revert collaborates with scholars based in Spain and United States. L Revert's co-authors include M Ingelmo, Xavier Bosch, E Mirapeix, Aleix Cases, Ma. de los Ángeles Calvo Torras, J Montolíu, A Darnell, Rodrigo Rodríguez Rodríguez, Alejandro López‐Soto and J López-Pedret and has published in prestigious journals such as European Respiratory Journal, American Journal of Kidney Diseases and Journal of Hypertension.

In The Last Decade

L Revert

39 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Revert Spain 14 297 216 121 104 85 41 538
Ettore Sabadini Italy 13 283 1.0× 347 1.6× 126 1.0× 244 2.3× 87 1.0× 24 747
Giuliana Lama Italy 15 186 0.6× 258 1.2× 330 2.7× 58 0.6× 42 0.5× 26 804
B Hory France 12 97 0.3× 492 2.3× 139 1.1× 50 0.5× 56 0.7× 43 757
Melinda McVicar United States 12 112 0.4× 178 0.8× 116 1.0× 45 0.4× 63 0.7× 33 578
Ruriko Nozawa Japan 14 203 0.7× 320 1.5× 107 0.9× 100 1.0× 41 0.5× 27 527
Angelo Testa France 9 116 0.4× 330 1.5× 75 0.6× 39 0.4× 44 0.5× 14 470
Hirokazu Niitani Japan 7 429 1.4× 136 0.6× 50 0.4× 126 1.2× 29 0.3× 32 604
Sharon Ford Australia 9 210 0.7× 178 0.8× 85 0.7× 44 0.4× 54 0.6× 14 464
Peter E. Gower United Kingdom 16 105 0.4× 204 0.9× 260 2.1× 93 0.9× 18 0.2× 25 652
BF Murphy Australia 9 135 0.5× 260 1.2× 31 0.3× 67 0.6× 24 0.3× 9 414

Countries citing papers authored by L Revert

Since Specialization
Citations

This map shows the geographic impact of L Revert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Revert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Revert more than expected).

Fields of papers citing papers by L Revert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Revert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Revert. The network helps show where L Revert may publish in the future.

Co-authorship network of co-authors of L Revert

This figure shows the co-authorship network connecting the top 25 collaborators of L Revert. A scholar is included among the top collaborators of L Revert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Revert. L Revert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cases, Aleix, J.M. Gaya, Wladimiro Jiménez, et al.. (1995). Reversible Decrease of Surface ß2-Adrenoceptor Number and Response in Lymphocytes of Patients with Pheochromocytoma. Clinical and Experimental Hypertension. 17(3). 537–549. 12 indexed citations
2.
Cases, Aleix, et al.. (1995). Effect of antihypertensive treatment on the increased β-adrenoceptor density in patients with essential hypertension. American Journal of Hypertension. 8(5). 487–493. 8 indexed citations
3.
Bosch, Xavier, E Mirapeix, José A. Font, et al.. (1994). [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].. PubMed. 102(11). 412–7. 2 indexed citations
4.
Almirall, Jaume, et al.. (1993). Penicillamine-lnduced Rapidly Progressive Glomerulonephritis in a Patient with Rheumatoid Arthritis. American Journal of Nephrology. 13(4). 286–288. 14 indexed citations
5.
Bosch, Xavier, Josep Font, E Mirapeix, et al.. (1993). Anti-Neutrophil Cytoplasmic Autoantibodies (ANCA): Antigenic Specificities and Clinical Associations. Advances in experimental medicine and biology. 336. 281–286. 6 indexed citations
6.
Bosch, Xavier, Eduard Mirapeix, Josep Font, et al.. (1992). Anti-myeloperoxidase Autoantibodies in Patients With Necrotizing Glomerular and Alveolar Capillaritis. American Journal of Kidney Diseases. 20(3). 231–239. 33 indexed citations
7.
Poch, Esteban, et al.. (1992). Calciphylaxis in a Hemodialysis Patient: Appearance After Parathyroidectomy During a Psoriatic Flare. American Journal of Kidney Diseases. 19(3). 285–288. 22 indexed citations
8.
Bosch, Xavier, et al.. (1992). Antimyeloperoxidase Autoantibody-associated Necrotizing Alveolar Capillaritis. American Review of Respiratory Disease. 146(5_pt_1). 1326–1329. 37 indexed citations
9.
Montoliu, Jesús, et al.. (1990). Henoch-Schönlein Purpura and IgA Nephropathy in Father and Son. ˜The œNephron journals/Nephron journals. 54(1). 77–79. 15 indexed citations
10.
Arrizabalaga, Pilar, E Mirapeix, A Darnell, Ma. de los Ángeles Calvo Torras, & L Revert. (1989). Cellular Immunity Analysis Using Monoclonal Antibodies in Human Glomerulonephritis. ˜The œNephron journals/Nephron journals. 53(1). 41–49. 10 indexed citations
11.
Cases, Aleix, A Botey, J.M. Gaya, et al.. (1989). Lymphocyte β2-Adrenergic Receptors in Essential Hypertension: Studies in Basal Conditions and After Dynamic Exercise. Clinical and Experimental Hypertension Part A Theory and Practice. 11(sup1). 303–309. 3 indexed citations
12.
Montolíu, J, et al.. (1989). [Prospective study of 75 episodes of sepsis in hemodialysed patients].. PubMed. 92(2). 47–51. 1 indexed citations
13.
Almirall, Jaume, Josep M. Campistol, Ma. de los Ángeles Calvo Torras, J López-Pedret, & L Revert. (1988). [Efficacy of calcium carbonate as a phosphorus-chelating agent in hemodialysis patients].. PubMed. 91(11). 409–12. 1 indexed citations
14.
Cases, Aleix, et al.. (1988). [Increase in number and exagerated increment during exercise of lymphocyte beta 2-adrenergic receptors in essential mild arterial hypertension].. PubMed. 91(15). 570–2. 1 indexed citations
15.
Botey, A, et al.. (1987). Malignant or accelerated hypertension in IgA nephropathy.. PubMed. 27(1). 1–7. 16 indexed citations
16.
Piera, Carlos, et al.. (1985). Changes in body compartments on different types of haemodialysis.. PubMed. 21. 235–40. 1 indexed citations
17.
Montolíu, J, et al.. (1985). Disseminated Visceral Infection with Mycobacterium fortuitum in a Hemodialysis Patient. American Journal of Nephrology. 5(3). 205–211. 7 indexed citations
18.
Montolíu, J, Laia Andreu‐Hayles, Ma. de los Ángeles Calvo Torras, et al.. (1983). Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.. PubMed. 19. 756–60. 14 indexed citations
19.
Arrizabalaga, Pilar, et al.. (1983). Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.. PubMed. 20. 572–6. 30 indexed citations
20.
Caralps, A, et al.. (1969). [Auto-transplantation of kidney for arterial hypertension of vascular etiology].. PubMed. 75(12). Suppl 12:469+–Suppl 12:469+. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026